EICHOR
● Active Not Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Condition: Obesity · Overweight · Type 2 Diabetes · Sponsor: Eli Lilly and Company
About this study
The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which they will enroll into either J2A-MC-GZP1, NCT06972459 (do not have type 2 diabetes) or J2A-MC-GZP2, NCT06972472 (have type 2 diabetes).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (80)
| Clinical Research Institute of Arizona (CRI) - Sun City West | Sun City West, Arizona, United States | — |
| Novak Clinical Research - Tucson - North La Cholla Boulevard | Tucson, Arizona, United States | — |
| Norcal Endocrinology & Internal Medicine | San Ramon, California, United States | — |
| Southern California Clinical Research | Santa Ana, California, United States | — |
| Care Access - Thousand Oaks | Thousand Oaks, California, United States | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand, Florida, United States | — |
| Innovation Medical Research Center - Fort Lauderdale | Fort Lauderdale, Florida, United States | — |
| Indago Research & Health Center, Inc | Hialeah, Florida, United States | — |
| Encore Medical Research | Hollywood, Florida, United States | — |
| West Orange Endocrinology P.A. | Ocoee, Florida, United States | — |
| Care Access - Tampa | Tampa, Florida, United States | — |
| Conquest Research | Winter Park, Florida, United States | — |
+ 68 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06993792